Assessment of a storage system to deliver uninterrupted therapeutic oxygen during power outages in resource-limited settings.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 24 04 2018
accepted: 07 01 2019
entrez: 7 2 2019
pubmed: 7 2 2019
medline: 14 11 2019
Statut: epublish

Résumé

Access to therapeutic oxygen remains a challenge in the effort to reduce pneumonia mortality among children in low- and middle-income countries. The use of oxygen concentrators is common, but their effectiveness in delivering uninterrupted oxygen is gated by reliability of the power grid. Often cylinders are employed to provide continuous coverage, but these can present other logistical challenges. In this study, we examined the use of a novel, low-pressure oxygen storage system to capture excess oxygen from a concentrator to be delivered to patients during an outage. A prototype was built and tested in a non-clinical trial in Jinja, Uganda. The trial was carried out at Jinja Regional Referral Hospital over a 75-day period. The flow rate of the unit was adjusted once per week between 0.5 and 5 liters per minute. Over the trial period, 1284 power failure episodes with a mean duration of 3.1 minutes (range 0.08 to 1720 minutes) were recorded. The low-pressure system was able to deliver oxygen over 56% of the 4,295 power outage minutes and cover over 99% of power outage events over the course of the study. These results demonstrate the technical feasibility of a method to extend oxygen availability and provide a basis for clinical trials.

Identifiants

pubmed: 30726247
doi: 10.1371/journal.pone.0211027
pii: PONE-D-18-12385
pmc: PMC6364892
doi:

Substances chimiques

Oxygen S88TT14065

Banques de données

Dryad
['10.5061/dryad.5m66621']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0211027

Déclaration de conflit d'intérêts

The commercial affiliation with The Global Good Fund I, LLC (www.globalgood.com) does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Références

Int J Tuberc Lung Dis. 2004 Sep;8(9):1138-41
pubmed: 15455602
Int J Tuberc Lung Dis. 2016 May;20(5):696-703
pubmed: 27084827
Int J Tuberc Lung Dis. 2009 May;13(5):587-93
pubmed: 19383191
Int J Tuberc Lung Dis. 2016 Aug;20(8):1130-4
pubmed: 27393551
J Glob Health. 2017 Jun;7(1):010411
pubmed: 28567280
Trials. 2015 Jul 09;16:297
pubmed: 26156116
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
J Infect Dev Ctries. 2010 Aug 04;4(7):419-24
pubmed: 20818088
Int J Tuberc Lung Dis. 2001 Jun;5(6):520-3
pubmed: 11409577
Bull World Health Organ. 2017 Apr 1;95(4):288-302
pubmed: 28479624
Ann Trop Paediatr. 2008 Mar;28(1):71-8
pubmed: 18318953
Afr Health Sci. 2008 Mar;8(1):61-4
pubmed: 19357737
Glob Health Sci Pract. 2013 Aug 14;1(2):249-61
pubmed: 25276537
Bull World Health Organ. 2009 Apr;87(4):263-70
pubmed: 19551234
Anaesthesia. 2013 Jul;68(7):706-12
pubmed: 23654218
Ann Trop Paediatr. 2002 Sep;22(3):209-12
pubmed: 12369483
Trop Med Int Health. 2006 Mar;11(3):367-72
pubmed: 16553917
Int J Tuberc Lung Dis. 2001 Jun;5(6):524-6
pubmed: 11409578
Can J Anaesth. 2002 Jan;49(1):8-12
pubmed: 11782322
Int J Tuberc Lung Dis. 2001 Jun;5(6):511-9
pubmed: 11409576
Bull World Health Organ. 2009 Oct;87(10):763-71
pubmed: 19876543
Ann Trop Paediatr. 2010;30(2):87-101
pubmed: 20522295
BMC Public Health. 2011 Apr 13;11 Suppl 3:S28
pubmed: 21501446
Lancet. 1996 Jun 8;347(9015):1597-9
pubmed: 8667871
Trials. 2017 Oct 27;18(1):502
pubmed: 29078810
Anaesthesia. 1991 Mar;46(3):217-9
pubmed: 2014901
Arch Dis Child. 2002 Feb;86(2):108-12
pubmed: 11827904
Respir Care. 2017 Dec;62(12):1582-1587
pubmed: 28951467
Bull World Health Organ. 2008 May;86(5):344-8
pubmed: 18545736
P N G Med J. 2010 Sep-Dec;53(3-4):126-38
pubmed: 23163183
J Trop Pediatr. 2018 Apr 1;64(2):97-103
pubmed: 28486654
J Trop Pediatr. 2012 Oct;58(5):389-93
pubmed: 22170511
Lancet Infect Dis. 2009 Apr;9(4):219-27
pubmed: 19324294

Auteurs

Ryan Calderon (R)

Intellectual Ventures Laboratory, Bellevue, Washington, United States of America.

Melissa C Morgan (MC)

Department of Pediatrics, University of California San Francisco, San Francisco, California, United States of America.
Institute for Global Health Sciences, University of California San Francisco, San Francisco, California, United States of America.
Maternal, Adolescent, Reproductive, and Child Health Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Mark Kuiper (M)

Intellectual Ventures Laboratory, Bellevue, Washington, United States of America.

Harriet Nambuya (H)

Department of Pediatrics, Jinja Regional Referral Hospital, Jinja, Uganda.

Nicholas Wangwe (N)

Department of Pediatrics, Jinja Regional Referral Hospital, Jinja, Uganda.

Akos Somoskovi (A)

Intellectual Ventures Global Good Fund, Bellevue, Washington, United States of America.

Daniel Lieberman (D)

Intellectual Ventures Laboratory, Bellevue, Washington, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH